Ongoing anticoagulant treatment does not seem to protect against severe COVID-19

(Karolinska Institutet) DOAC (direct oral anticoagulant) pills are used in the treatment of atrial fibrillation by preventing blood clots. Even though blood clots are thought to contribute to complications from the new coronavirus infection, users of this class of drug do not seem to be protected against severe COVID-19, reports a large Swedish registry study from Karolinska Institutet published in The Journal of Internal Medicine.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news